用 omalizumab 治疗的严重慢性疹症治疗控制治疗的预测因素
Miguel Proença1, João Marcelino1,2, João Vieira1
1Immunology and Allergy Department, Unidade Local de Saúde Arrábida, Portugal.
Asia Pacific allergy
|September 11, 2025
概括
老年患者在慢性自发性疹治疗中表现出更高的奥马利祖马布 (OMA) 成功率,但需要更长的剂量减少间隔. 抗甲状腺过氧化酶抗体和抗dsDNA等生物标志物可以预测OMA反应.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏 过敏是一种过敏.
- 皮肤病学 皮肤病学
背景情况:
- 有限的现实世界数据存在于预测奥马利祖马布 (OMA) 治疗严重慢性自发性疹 (CSU) 治疗结果的生物标志物上.
- 识别预测生物标志物对于优化CSU患者的OMA治疗至关重要.
研究的目的:
- 为了确定预测治疗反应的生物标志物,在接受OMA的严重慢性自发性疹患者中.
- 分析患者人口统计,自身抗体和OMA治疗疗效之间的相关性.
主要方法:
- 一项追溯观察性研究,对56名重症CSU患者进行了OMA治疗.
- 统计分析包括单向ANOVA和线性回归来评估相关性.
主要成果:
- 患者被分为三个响应组:成功降低剂量 (46.4%),用剂量限制控制疾病 (33.9%) 和响应不佳 (19.6%).
- 年龄较大与良好的反应相关,剂量减少的时间较长.
- 增加的IgG-抗甲状腺过氧化酶抗体,抗dsDNA抗体,以及高的IgG-抗甲状腺过氧化酶/总IgE比率与较差的OMA反应有关.
结论:
- 老年患者通常对OMA反应更好,但可能需要更多的时间进行剂量定位.
- 抗IgG-抗甲状腺过氧化酶抗体,抗dsDNA抗体,以及IgG-抗甲状腺过氧化酶/总IgE比率可能表明对OMA疗法的耐药性.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Antiasthma Drugs: Leukotriene Modifiers
1.8K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.8K
Hypersensitivities
7.2K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
7.2K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
409
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
409
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K


